Cover
Cover - shares | 6 Months Ended | |
Jun. 30, 2021 | Jul. 31, 2021 | |
Cover [Abstract] | ||
Document Type | 10-Q | |
Amendment Flag | false | |
Document Quarterly Report | true | |
Document Transition Report | false | |
Document Period End Date | Jun. 30, 2021 | |
Document Fiscal Period Focus | Q2 | |
Document Fiscal Year Focus | 2021 | |
Current Fiscal Year End Date | --12-31 | |
Entity File Number | 000-53183 | |
Entity Registrant Name | KALLO INC. | |
Entity Central Index Key | 0001389034 | |
Entity Incorporation, State or Country Code | NV | |
Entity Address, Address Line One | 255 Duncan Mill Road | |
Entity Address, Address Line Two | Suite 504 | |
Entity Address, City or Town | Toronto | |
Entity Address, State or Province | ON | |
Entity Address, Country | CA | |
Entity Address, Postal Zip Code | M3B 3H9 | |
City Area Code | (416) | |
Local Phone Number | 246-9997 | |
Entity Current Reporting Status | Yes | |
Entity Interactive Data Current | Yes | |
Entity Filer Category | Non-accelerated Filer | |
Entity Small Business | true | |
Entity Emerging Growth Company | false | |
Entity Shell Company | true | |
Entity Common Stock, Shares Outstanding | 1,147,698,199 |
Consolidated Balance Sheets (Un
Consolidated Balance Sheets (Unaudited) - USD ($) | Jun. 30, 2021 | Dec. 31, 2020 |
Current Assets: | ||
Cash | $ 43 | |
Prepaid expenses | 12,572 | |
Total Current Assets | 12,615 | |
TOTAL ASSETS | 12,615 | |
Current Liabilities: | ||
Accounts payable and accrued liabilities | 4,643,851 | 4,359,752 |
Convertible loans payable – third parties | 302,455 | 290,133 |
Short term loans payable | 280,733 | 78,397 |
Convertible loans payable – related parties | 1,036,678 | 993,812 |
Liability for issuable shares | 44,268,440 | 37,149,790 |
Total Current Liabilities | 50,532,157 | 42,871,884 |
TOTAL LIABILITIES | 50,532,157 | 42,871,884 |
Stockholders Deficiency | ||
Preferred stock, $0.00001 par value, 100,000,000 shares authorized, 95,000,000 Series A preferred shares and 5,000,000 Series B preferred shares issued and outstanding | 1,000 | 950 |
Common stock, $0.00001 par value, 1,150,000,000 shares authorized, 1,147,698,199 and 1,147,698,199 shares issued and outstanding, respectively. | 11,478 | 11,478 |
Additional paid-in capital | 42,121,416 | 41,920,116 |
Assignment of liabilities | (3,455,111) | (3,455,111) |
Accumulated deficit | (89,198,325) | (81,349,317) |
Total Stockholders Deficiency | (50,519,542) | (42,871,884) |
TOTAL LIABILITIES AND STOCKHOLDERS DEFICIENCY | $ 12,615 |
Consolidated Balance Sheets (_2
Consolidated Balance Sheets (Unaudited) (Parenthetical) - $ / shares | Jun. 30, 2021 | Dec. 31, 2020 |
Preferred Stock, Par or Stated Value Per Share | $ 0.00001 | $ 0.00001 |
Preferred Stock, Shares Authorized | 100,000,000 | 100,000,000 |
Common Stock, Par or Stated Value Per Share | $ 0.00001 | $ 0.00001 |
Common Stock, Shares Authorized | 1,150,000,000 | 1,150,000,000 |
Common Stock, Shares, Issued | 1,147,698,199 | 1,147,698,199 |
Common Stock, Shares, Outstanding | 1,147,698,199 | 1,147,698,199 |
Preferred Stock [Member] | Preferred Class A [Member] | ||
Preferred Stock, Shares Issued | 95,000,000 | 95,000,000 |
Preferred Stock, Shares Outstanding | 95,000,000 | 95,000,000 |
Preferred Stock [Member] | Preferred Class B [Member] | ||
Preferred Stock, Shares Issued | 5,000,000 | 5,000,000 |
Preferred Stock, Shares Outstanding | 5,000,000 | 5,000,000 |
Consolidated Statements of Oper
Consolidated Statements of Operations (Unaudited) - USD ($) | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2021 | Jun. 30, 2020 | Jun. 30, 2021 | Jun. 30, 2020 | |
Operating Expenses | ||||
General and administration | $ 7,426,101 | $ 100,054 | $ 7,660,029 | $ 198,753 |
Selling and marketing | 19,501 | 19,501 | 18,563 | |
Operating loss | (7,445,602) | (100,054) | (7,679,530) | (217,316) |
Interest and financing costs | (27,747) | (27,747) | (55,188) | (55,493) |
Foreign exchange (loss) gain | (63,134) | (140,117) | (114,290) | 166,106 |
Net Loss | $ (7,536,483) | $ (267,918) | $ (7,849,008) | $ (106,703) |
Basic and diluted net loss per share | $ (0.01) | $ 0 | $ (0.01) | $ 0 |
Weighted average shares used in calculating Basic and diluted net loss per share | 1,147,698,199 | 1,147,698,199 | 1,147,698,199 | 1,147,698,199 |
Consolidated Statements of Chan
Consolidated Statements of Changes in Stockholders' Deficiency Equity (Unaudited) - USD ($) | Preferred Stock [Member] | Common Stock [Member] | Additional Paid-in Capital [Member] | Assignment Of Liabilities [Member] | Retained Earnings [Member] | Total |
Beginning balance, value at Dec. 31, 2020 | $ 950 | $ 11,478 | $ 41,920,116 | $ (3,455,111) | $ (81,349,317) | $ (42,871,884) |
Shares, Outstanding, Beginning Balance at Dec. 31, 2020 | 95,000,000 | 1,147,698,199 | ||||
Shares issued to director | $ 50 | 201,300 | 201,350 | |||
Shares issued to director, in shares | 5,000,000 | |||||
Net loss | (312,525) | (312,525) | ||||
Ending balance, value at Mar. 31, 2021 | $ 1,000 | $ 11,478 | 42,121,416 | (3,455,111) | (81,661,842) | (42,983,059) |
Shares, Outstanding, Ending Balance at Mar. 31, 2021 | 100,000,000 | 1,147,698,199 | ||||
Beginning balance, value at Dec. 31, 2020 | $ 950 | $ 11,478 | 41,920,116 | (3,455,111) | (81,349,317) | (42,871,884) |
Shares, Outstanding, Beginning Balance at Dec. 31, 2020 | 95,000,000 | 1,147,698,199 | ||||
Net loss | (7,849,008) | |||||
Ending balance, value at Jun. 30, 2021 | $ 1,000 | $ 11,478 | 42,121,416 | (3,455,111) | (89,198,325) | (50,519,542) |
Shares, Outstanding, Ending Balance at Jun. 30, 2021 | 100,000,000 | 1,147,698,199 | ||||
Beginning balance, value at Mar. 31, 2021 | $ 1,000 | $ 11,478 | 42,121,416 | (3,455,111) | (81,661,842) | (42,983,059) |
Shares, Outstanding, Beginning Balance at Mar. 31, 2021 | 100,000,000 | 1,147,698,199 | ||||
Net loss | (7,536,483) | (7,536,483) | ||||
Ending balance, value at Jun. 30, 2021 | $ 1,000 | $ 11,478 | $ 42,121,416 | $ (3,455,111) | $ (89,198,325) | $ (50,519,542) |
Shares, Outstanding, Ending Balance at Jun. 30, 2021 | 100,000,000 | 1,147,698,199 |
Consolidated Statements of Cash
Consolidated Statements of Cash Flows (Unaudited) - USD ($) | 6 Months Ended | |
Jun. 30, 2021 | Jun. 30, 2020 | |
CASH FLOWS FROM OPERATING ACTIVITIES | ||
Net Income (Loss) | $ (7,849,008) | $ (106,703) |
Adjustment to reconcile net loss to cash used in operating activities: | ||
Stock based compensation | 7,295,600 | |
Interest and financing costs | 55,188 | 55,493 |
Unrealized foreign exchange loss (gain) | 114,234 | (168,383) |
Changes in operating assets and liabilities: | ||
Increase (decrease) in accounts payable and accrued liabilities | 194,730 | 219,242 |
(Increase) in prepaid expenses | (12,572) | |
NET CASH USED IN OPERATING ACTIVITIES | (201,828) | (351) |
CASH FLOWS FROM FINANCING ACTIVITIES | ||
Proceeds from short term loans payable | 201,871 | 351 |
NET CASH PROVIDED BY FINANCING ACTIVITIES | 201,871 | 351 |
NET (DECREASE) INCREASE IN CASH | 43 | |
CASH - BEGINNING OF PERIOD | ||
CASH - END OF PERIOD | 43 | |
SUPPLEMENTAL CASH FLOW INFORMATION | ||
Income tax paid | ||
Interest paid | ||
SUPPLEMENTAL SCHEDULE OF NON-CASH INVESTING AND FINANCING ACTIVITIES | ||
Settlement of accounts payable by FE Pharmacy, Inc. | 7,443 | |
Issuance of preferred stock previously accrued | $ 201,350 |
BUSINESS AND GOING CONCERN
BUSINESS AND GOING CONCERN | 6 Months Ended |
Jun. 30, 2021 | |
Accounting Policies [Abstract] | |
BUSINESS AND GOING CONCERN | NOTE 1 – BUSINESS AND GOING CONCERN Organization Kallo Inc. (Kallo or the Company) develops customized health care solutions designed to improve or enhance the delivery of care in the countries and regions we serve. Going Concern The accompanying unaudited consolidated financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The amounts of assets and liabilities in the consolidated financial statements do not purport to represent realizable or settlement values. The Company has incurred operating losses since inception and has an accumulated deficit and a working capital deficit at June 30, 2021. The Company is expected to incur additional losses as it executes its go to market strategy. This raises substantial doubt about the Companys ability to continue as a going concern. The Company has met its historical working capital requirements from the sale of common shares and short term loans. In order to not burden the Company, the officer/stockholder has agreed to provide funding to the Company to pay its annual audit fees, filing costs and legal fees as long as the board of directors deems it necessary. However, there can be no assurance that such financial support shall be ongoing or available on terms or conditions acceptable to the Company. These consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty. |
ACCOUNTING POLICIES AND OPERATI
ACCOUNTING POLICIES AND OPERATIONS | 6 Months Ended |
Jun. 30, 2021 | |
Accounting Policies [Abstract] | |
ACCOUNTING POLICIES AND OPERATIONS | NOTE 2 – ACCOUNTING POLICIES AND OPERATIONS Basis of Presentation The accompanying unaudited consolidated financial statements of the Company have been prepared in conformity with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10-Q and Article 8-03 of Regulation S-X related to smaller reporting companies. These unaudited consolidated financial statements should be read in conjunction with the annual audited consolidated financial statements and notes, which are included as part of the Companys Form 10-K filed with the SEC for the year ended December 31, 2020. Operating results for the periods presented are not necessarily indicative of the results that may be expected for the full year. Notes to the financial statements which substantially duplicate the disclosure contained in the audited consolidated financial statements for fiscal year ended December 31, 2020 as reported in the 10-K have been omitted. In the opinion of management, all adjustments, consisting only of normal recurring adjustments, considered necessary for a fair presentation, have been included in the accompanying unaudited consolidated financial statements. Recently Adopted Accounting Pronouncements In December 2019, the FASB issued ASU 2019-12, Simplifying the Accounting for Income Taxes, which simplifies the accounting for income taxes, eliminates certain exceptions within ASC 740, Income Taxes, and clarifies certain aspects of the current guidance to promote consistent application among reporting entities. The guidance is effective for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years, with early adoption permitted. Upon adoption, the Company must apply certain aspects of this standard retrospectively for all periods presented while other aspects are applied on a modified retrospective basis through a cumulative-effect adjustment to retained earnings as of the beginning of the fiscal year of adoption. The adoption of this standard did not have a material impact on the Companys consolidated financial statements Management believes that other recent accounting pronouncements issued by the FASB, including its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the Securities and Exchange Commission do not have a material impact on the Companys present or near future consolidated financial statements. KALLO INC. Notes to Consolidated Financial Statements June 30, 2021 (Amounts expressed in US dollars) (Unaudited) |
COMMON STOCK
COMMON STOCK | 6 Months Ended |
Jun. 30, 2021 | |
Equity [Abstract] | |
COMMON STOCK | NOTE 3 – COMMON STOCK During the six months ended June 30, 2021, the Company issued 5,000,000 201,350 On April 8, 2017, the Company entered into an agreement with FE Pharmacy Inc., a company controlled by a shareholder of Kallo, and a related party, whereby in consideration for the issuance of 475,000,000 common stock of Kallo, FE Pharmacy Inc. assumed and will pay all of the Companys outstanding indebtedness as at April 7, 2017. The 475,000,000 4,135,037 |
RELATED PARTY TRANSACTIONS
RELATED PARTY TRANSACTIONS | 6 Months Ended |
Jun. 30, 2021 | |
Related Party Transactions [Abstract] | |
RELATED PARTY TRANSACTIONS | NOTE 4 – RELATED PARTY TRANSACTIONS During the six months ended June 30, 2021, the Board of Directors approved the issuance of 2,440,000,000 24,400 7,295,600 During the year ended December 31, 2020, the Board of Directors approved the issuance of 2,708,000,000 27,080 35,398,420 During the year ended December 31, 2019, the Board of Directors approved the issuance of 57,000,000 570 1,373,130 During the year ended December 31, 2019, the Company designated 5,000,000 of is preferred stock as Series B preferred stock, each of which has 1,000 votes and are not convertible. The Company, will not, without the approval or express written consent of the all the holders of the Series B preferred stock (i) establish, create, authorize or approve the issuance of any series or class of preferred stock (ii) change any of the rights, privileges or preferences of the Series B preferred stock or (iii) redeem the Series B preferred stock.. During the year ended December 31, 2019, the Board of Directors approved the issuance of 5,000,000 Series B preferred shares to a director as compensation for services rendered and their fair value were deemed to be $201,350 based on the voting rights of the preferred shares relative to the fair value of the Company at the date of the approved issuance. These shares were issued during the six months ended June 30, 2021. Included in liability for issuable shares is 3,731,005 common shares valued at $149,240 and approved for issuance to a family of the controlling shareholder of FE Pharmacy Inc as compensation during 2018 which will be issued after the Company is able to increase its authorized number of common shares. The transfer agent has erroneously issued these shares in spite of the Companys instructions to wait for the increase in authorized number of common shares. Included in accounts payable and accrued liabilities is an amount of $ 1,858,268 1,675,108 Included in convertible loans payable to related parties is an amount of $ 1,036,678 993,812 Included in short term loans payable is an amount of $263,167 61,297 KALLO INC. Notes to Consolidated Financial Statements June 30, 2021 (Amounts expressed in US dollars) (Unaudited) |
CONVERTIBLE LOANS PAYABLE
CONVERTIBLE LOANS PAYABLE - USD ($) | 6 Months Ended | |
Jun. 30, 2021 | Dec. 31, 2020 | |
Short-term Debt [Line Items] | ||
CONVERTIBLE LOANS PAYABLE | NOTE 5 – CONVERTIBLE LOANS PAYABLE Schedule of Convertible Loans Payable June 30, 2021 December 31, Convertible promissory notes bearing interest at 15% per annum – third parties $ 302,455 $ 290,133 Convertible promissory notes bearing interest at 15% per annum – related parties 1,036,678 993,812 Convertible loans payable $ 1,339,133 $ 1,283,945 The Convertible loans payable bear 15% interest per annum and are convertible at a fixed price at any time during their 1 year term. The Company has the option to pay the note at any time. The Company analyzed the conversion option for derivative accounting consideration under ASC Topic 815-40, Derivatives and Hedging – Contract in Entitys Own Stock and concluded that the embedded conversion was a derivative but the fair value of the feature was zero. The total outstanding notes is $1,339,133, including accrued interest, of which $1,036,678 is to from related parties. Interest of $ 55,188 | |
Convertible loans payable | $ 1,339,133 | $ 1,283,945 |
Convertible promissory notes bearing interest at 15% per annum - third parties | ||
Short-term Debt [Line Items] | ||
Convertible loans payable | 302,455 | 290,133 |
Convertible promissory notes bearing interest at 15% per annum - related parties | ||
Short-term Debt [Line Items] | ||
Convertible loans payable | $ 1,036,678 | $ 993,812 |
SHORT TERM LOANS PAYABLE
SHORT TERM LOANS PAYABLE | 6 Months Ended |
Jun. 30, 2021 | |
Debt Disclosure [Abstract] | |
SHORT TERM LOANS PAYABLE | NOTE 6 – SHORT TERM LOANS PAYABLE Schedule of Short Term Loans payable June 30, 2021 December 31, 2020 Non-interest bearing short term funding from third party $ 17,566 $ 17,100 Non-interest bearing short term funding from director 263,167 61,297 Short term loans payable $ 280,733 $ 78,397 As of June 30, 2021, the balance of $ 280,733 21,772 KALLO INC. Notes to Consolidated Financial Statements June 30, 2021 (Amounts expressed in US dollars) (Unaudited) |
COMMITMENTS AND CONTINGENCIES
COMMITMENTS AND CONTINGENCIES | 6 Months Ended |
Jun. 30, 2021 | |
Commitments and Contingencies Disclosure [Abstract] | |
COMMITMENTS AND CONTINGENCIES | NOTE 7 – COMMITMENTS AND CONTINGENCIES Contingencies On April 21, 2017, an ex-employee of Kallo obtained a judgement ordering Kallo to pay Canadian $ 135,959 On October 24, 2016, a consultant obtained a judgement ordering Kallo to pay Canadian $ 34,924 On October 6, 2017, Thornley Fallis Communications Inc. (Thornley) commenced a third party claim against Kallo concerning monies that Kallo allegedly owed to Thornley for redesign of a website and public relation services. Thornley is seeking damages in the amount of Canadian $169,345 plus interest on the amounts outstanding and indemnification of the costs of the action. There is also a claim by Commercial Credit Adjusters on behalf of Northwest Company for payment of Canadian $34,000. Canada Revenue Agency has assessed the Company for unpaid Canadian $ 83,617 Responsibility for payments of the above claims has been assumed by FE Pharmacy Inc. under the terms of the agreement mentioned in Note 3. |
ACCOUNTING POLICIES AND OPERA_2
ACCOUNTING POLICIES AND OPERATIONS (Policies) | 6 Months Ended |
Jun. 30, 2021 | |
Accounting Policies [Abstract] | |
Basis of Presentation | Basis of Presentation The accompanying unaudited consolidated financial statements of the Company have been prepared in conformity with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10-Q and Article 8-03 of Regulation S-X related to smaller reporting companies. These unaudited consolidated financial statements should be read in conjunction with the annual audited consolidated financial statements and notes, which are included as part of the Companys Form 10-K filed with the SEC for the year ended December 31, 2020. Operating results for the periods presented are not necessarily indicative of the results that may be expected for the full year. Notes to the financial statements which substantially duplicate the disclosure contained in the audited consolidated financial statements for fiscal year ended December 31, 2020 as reported in the 10-K have been omitted. In the opinion of management, all adjustments, consisting only of normal recurring adjustments, considered necessary for a fair presentation, have been included in the accompanying unaudited consolidated financial statements. |
Recently Adopted Accounting Pronouncements | Recently Adopted Accounting Pronouncements In December 2019, the FASB issued ASU 2019-12, Simplifying the Accounting for Income Taxes, which simplifies the accounting for income taxes, eliminates certain exceptions within ASC 740, Income Taxes, and clarifies certain aspects of the current guidance to promote consistent application among reporting entities. The guidance is effective for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years, with early adoption permitted. Upon adoption, the Company must apply certain aspects of this standard retrospectively for all periods presented while other aspects are applied on a modified retrospective basis through a cumulative-effect adjustment to retained earnings as of the beginning of the fiscal year of adoption. The adoption of this standard did not have a material impact on the Companys consolidated financial statements Management believes that other recent accounting pronouncements issued by the FASB, including its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the Securities and Exchange Commission do not have a material impact on the Companys present or near future consolidated financial statements. KALLO INC. Notes to Consolidated Financial Statements June 30, 2021 (Amounts expressed in US dollars) (Unaudited) |
CONVERTIBLE LOANS PAYABLE (Tabl
CONVERTIBLE LOANS PAYABLE (Tables) | 6 Months Ended |
Jun. 30, 2021 | |
Debt Disclosure [Abstract] | |
Schedule of Convertible Loans Payable | Schedule of Convertible Loans Payable |
CONVERTIBLE LOANS PAYABLE | June 30, 2021 December 31, Convertible promissory notes bearing interest at 15% per annum – third parties $ 302,455 $ 290,133 Convertible promissory notes bearing interest at 15% per annum – related parties 1,036,678 993,812 Convertible loans payable $ 1,339,133 $ 1,283,945 |
SHORT TERM LOANS PAYABLE (Table
SHORT TERM LOANS PAYABLE (Tables) | 6 Months Ended |
Jun. 30, 2021 | |
Debt Disclosure [Abstract] | |
Schedule of Short Term Loans payable | Schedule of Short Term Loans payable |
SHORT TERM LOANS PAYABLE | June 30, 2021 December 31, 2020 Non-interest bearing short term funding from third party $ 17,566 $ 17,100 Non-interest bearing short term funding from director 263,167 61,297 Short term loans payable $ 280,733 $ 78,397 |
COMMON STOCK (Details Narrative
COMMON STOCK (Details Narrative) - USD ($) | 3 Months Ended | 6 Months Ended | ||
Mar. 31, 2021 | Jun. 30, 2021 | Dec. 31, 2020 | Apr. 07, 2017 | |
Accumulated Other Comprehensive Income (Loss) [Line Items] | ||||
Stock Issued During the Period to Directot, Value | $ 201,350 | |||
Shares Issuable for Assignment of Liabilities | 475,000,000 | |||
Assignment of Liabilities | $ (3,455,111) | $ (3,455,111) | $ 4,135,037 | |
Preferred Stock [Member] | ||||
Accumulated Other Comprehensive Income (Loss) [Line Items] | ||||
Stock Issued During the Period to Directot, Value | $ 50 | |||
Preferred Stock [Member] | Series B Preferred Stock [Member] | Director [Member] | ||||
Accumulated Other Comprehensive Income (Loss) [Line Items] | ||||
Preferred Stock, Shares Issued | 5,000,000 | |||
Stock Issued During the Period to Directot, Value | $ 201,350 |
RELATED PARTY TRANSACTIONS (Det
RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($) | 6 Months Ended | 12 Months Ended | ||
Jun. 30, 2021 | Jun. 30, 2020 | Dec. 31, 2020 | Dec. 31, 2019 | |
Related Party Transaction [Line Items] | ||||
Share-based Payment Arrangement, Noncash Expense | $ 7,295,600 | |||
Accounts Payable and Accrued Liabilities, Current | 4,643,851 | $ 4,359,752 | ||
Accounts Payable, Related Parties, Current | 1,036,678 | 993,812 | ||
Loans Payable, Current | $ 280,733 | $ 78,397 | ||
Director [Member] | ||||
Related Party Transaction [Line Items] | ||||
Common Stock to be Issued, Shares | 2,440,000,000 | 2,708,000,000 | 57,000,000 | |
Common Stock to be Issued, Value | 24,400 | 27,080 | 570 | |
Share-based Payment Arrangement, Noncash Expense | $ 7,295,600 | $ 35,398,420 | $ 1,373,130 | |
Accounts Payable and Accrued Liabilities, Current | 1,858,268 | 1,675,108 | ||
Accounts Payable, Related Parties, Current | 1,036,678 | 993,812 | ||
Loans Payable, Current | $ 263,167 | $ 61,297 |
SHORT TERM LOANS PAYABLE (Detai
SHORT TERM LOANS PAYABLE (Details) - USD ($) | Jun. 30, 2021 | Dec. 31, 2020 |
Short-term Debt [Line Items] | ||
Short term loans payable | $ 280,733 | $ 78,397 |
Non-interest bearing short term funding from third parties | ||
Short-term Debt [Line Items] | ||
Short term loans payable | 17,566 | 17,100 |
Non-interest bearing short term funding from related parties | ||
Short-term Debt [Line Items] | ||
Short term loans payable | $ 263,167 | $ 61,297 |
CONVERTIBLE LOANS PAYABLE (Deta
CONVERTIBLE LOANS PAYABLE (Details Narrative) - USD ($) | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2021 | Jun. 30, 2020 | Jun. 30, 2021 | Jun. 30, 2020 | |
Debt Disclosure [Abstract] | ||||
Interest and Debt Expense | $ 27,747 | $ 27,747 | $ 55,188 | $ 55,493 |
SHORT TERM LOANS PAYABLE (Det_2
SHORT TERM LOANS PAYABLE (Details Narrative) | Jun. 30, 2021USD ($) | Jun. 30, 2021CAD ($) | Dec. 31, 2020USD ($) |
Debt Disclosure [Abstract] | |||
Loans Payable, Current | $ 280,733 | $ 78,397 | |
Loan from Third Party | $ 21,772 |
COMMITMENTS AND CONTINGENCIES (
COMMITMENTS AND CONTINGENCIES (Details Narrative) - CAD ($) | Oct. 06, 2017 | Apr. 21, 2017 | Oct. 24, 2016 | Jun. 30, 2021 |
Canada Revenue Agency [Member] | ||||
Loss Contingencies [Line Items] | ||||
Taxes Payable | $ 83,617 | |||
Judicial Ruling [Member] | ||||
Loss Contingencies [Line Items] | ||||
Unpaid Wages and Expenses | $ 135,959 | |||
Unpaid Fees | $ 34,924 | |||
Pending Litigation [Member] | ||||
Loss Contingencies [Line Items] | ||||
Litigation Description | On October 6, 2017, Thornley Fallis Communications Inc. (Thornley) commenced a third party claim against Kallo concerning monies that Kallo allegedly owed to Thornley for redesign of a website and public relation services. | |||
Litigation, Damage Sought | Thornley is seeking damages in the amount of Canadian $169,345 plus interest on the amounts outstanding and indemnification of the costs of the action. | There is also a claim by Commercial Credit Adjusters on behalf of Northwest Company for payment of Canadian $34,000. |